Calpain-1 weakens the nuclear envelope and promotes the release of neutrophil extracellular traps.


Journal

Cell communication and signaling : CCS
ISSN: 1478-811X
Titre abrégé: Cell Commun Signal
Pays: England
ID NLM: 101170464

Informations de publication

Date de publication:
09 Sep 2024
Historique:
received: 09 02 2024
accepted: 09 08 2024
medline: 10 9 2024
pubmed: 10 9 2024
entrez: 9 9 2024
Statut: epublish

Résumé

The inducers of neutrophil extracellular trap (NET) formation are heterogeneous and consequently, there is no specific pathway or signature molecule indispensable for NET formation. But certain events such as histone modification, chromatin decondensation, nuclear envelope breakdown, and NET release are ubiquitous. During NET formation, neutrophils drastically rearrange their cytoplasmic, granular and nuclear content. Yet, the exact mechanism for decoding each step during NET formation still remains elusive. Here, we investigated the mechanism of nuclear envelope breakdown during NET formation. Immunofluorescence microscopic evaluation revealed a gradual disintegration of outer nuclear membrane protein nesprin-1 and alterations in nuclear morphology during NET formation. MALDI-TOF analysis of NETs that had been generated by various inducers detected the accumulation of nesprin-1 fragments. This suggests that nesprin-1 degradation occurs before NET release. In the presence of a calpain-1, inhibitor nesprin-1 degradation was decreased in calcium driven NET formation. Microscopic evaluation confirmed that the disintegration of the lamin B receptor (LBR) and the collapse of the actin cytoskeleton occurs in early and later phases of NET release, respectively. We conclude that the calpain-1 degrades nesprin-1, orchestrates the weakening of the nuclear membrane, contributes to LBR disintegration, and promoting DNA release and finally, NETs formation.

Identifiants

pubmed: 39252008
doi: 10.1186/s12964-024-01785-6
pii: 10.1186/s12964-024-01785-6
doi:

Substances chimiques

Calpain EC 3.4.22.-
Lamin B Receptor 0
Nerve Tissue Proteins 0
SYNE1 protein, human 0
Nuclear Proteins 0
Receptors, Cytoplasmic and Nuclear 0
CAPN1 protein, human EC 3.4.22.52
Calcium SY7Q814VUP
Cytoskeletal Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

435

Informations de copyright

© 2024. The Author(s).

Références

Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V, et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007;176(2):231–41.
pubmed: 17210947 pmcid: 2063942 doi: 10.1083/jcb.200606027
Mahajan A, Gruneboom A, Petru L, Podolska MJ, Kling L, Maueroder C, et al. Frontline Science: Aggregated neutrophil extracellular traps prevent inflammation on the neutrophil-rich ocular surface. J Leukoc Biol. 2019;105(6):1087–98.
pubmed: 30977943 doi: 10.1002/JLB.HI0718-249RR
Schauer C, Janko C, Munoz LE, Zhao Y, Kienhofer D, Frey B, et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat Med. 2014;20(5):511–7.
pubmed: 24784231 doi: 10.1038/nm.3547
Kenny EF, Herzig A, Kruger R, Muth A, Mondal S, Thompson PR, et al. Diverse stimuli engage different neutrophil extracellular trap pathways. Elife. 2017;6:e2443.
doi: 10.7554/eLife.24437
Leshner M, Wang S, Lewis C, Zheng H, Chen XA, Santy L, et al. PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures. Front Immunol. 2012;3:307.
pubmed: 23060885 pmcid: 3463874 doi: 10.3389/fimmu.2012.00307
Kienhofer D, Hahn J, Stoof J, Csepregi JZ, Reinwald C, Urbonaviciute V, et al. Experimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps. JCI Insight. 2017;2(10):e92920.
pubmed: 28515366 pmcid: 5436535 doi: 10.1172/jci.insight.92920
Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010;207(9):1853–62.
pubmed: 20733033 pmcid: 2931169 doi: 10.1084/jem.20100239
Lewis HD, Liddle J, Coote JE, Atkinson SJ, Barker MD, Bax BD, et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat Chem Biol. 2015;11(3):189–91.
pubmed: 25622091 pmcid: 4397581 doi: 10.1038/nchembio.1735
Boeltz S, Amini P, Anders HJ, Andrade F, Bilyy R, Chatfield S, et al. To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps. Cell Death Differ. 2019;26(3):395–408.
pubmed: 30622307 pmcid: 6370810 doi: 10.1038/s41418-018-0261-x
Rajgor D, Shanahan CM. Nesprins: from the nuclear envelope and beyond. Expert Rev Mol Med. 2013;15:e5.
pubmed: 23830188 pmcid: 3733404 doi: 10.1017/erm.2013.6
Kiseleva E, Goldberg MW, Cronshaw J, Allen TD. The nuclear pore complex: structure, function, and dynamics. Crit Rev Eukaryot Gene Expr. 2000;10(1):101–12.
pubmed: 10813398 doi: 10.1615/CritRevEukarGeneExpr.v10.i1.110
Young KG, Kothary R. Spectrin repeat proteins in the nucleus. BioEssays. 2005;27(2):144–52.
pubmed: 15666356 doi: 10.1002/bies.20177
Haque F, Lloyd DJ, Smallwood DT, Dent CL, Shanahan CM, Fry AM, et al. SUN1 interacts with nuclear lamin A and cytoplasmic nesprins to provide a physical connection between the nuclear lamina and the cytoskeleton. Mol Cell Biol. 2006;26(10):3738–51.
pubmed: 16648470 pmcid: 1488999 doi: 10.1128/MCB.26.10.3738-3751.2006
Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev. 2003;83(3):731–801.
pubmed: 12843408 doi: 10.1152/physrev.00029.2002
Katsube M, Kato T, Kitagawa M, Noma H, Fujita H, Kitagawa S. Calpain-mediated regulation of the distinct signaling pathways and cell migration in human neutrophils. J Leukoc Biol. 2008;84(1):255–63.
pubmed: 18443189 doi: 10.1189/jlb.0907664
Momeni HR. Role of calpain in apoptosis. Cell J. 2011;13(2):65–72.
pubmed: 23507938 pmcid: 3584455
Weber H, Huhns S, Luthen F, Jonas L. Calpain-mediated breakdown of cytoskeletal proteins contributes to cholecystokinin-induced damage of rat pancreatic acini. Int J Exp Pathol. 2009;90(4):387–99.
pubmed: 19659897 pmcid: 2741149 doi: 10.1111/j.1365-2613.2009.00638.x
Mellgren RL. Proteolysis of nuclear proteins by mu-calpain and m-calpain. J Biol Chem. 1991;266(21):13920–4.
pubmed: 1649832 doi: 10.1016/S0021-9258(18)92789-4
Lokuta MA, Nuzzi PA, Huttenlocher A. Calpain regulates neutrophil chemotaxis. Proc Natl Acad Sci U S A. 2003;100(7):4006–11.
pubmed: 12649322 pmcid: 153038 doi: 10.1073/pnas.0636533100
Gosswein S, Lindemann A, Mahajan A, Maueroder C, Martini E, Patankar J, et al. Citrullination Licenses Calpain to Decondense Nuclei in Neutrophil Extracellular Trap Formation. Front Immunol. 2019;10:2481.
pubmed: 31695698 pmcid: 6817590 doi: 10.3389/fimmu.2019.02481
Rosner M, Schipany K, Hengstschlager M. Merging high-quality biochemical fractionation with a refined flow cytometry approach to monitor nucleocytoplasmic protein expression throughout the unperturbed mammalian cell cycle. Nat Protoc. 2013;8(3):602–26.
pubmed: 23449254 doi: 10.1038/nprot.2013.011
Ashhurst TM, Marsh-Wakefield F, Putri GH, Spiteri AG, Shinko D, Read MN, et al. Integration, exploration, and analysis of high-dimensional single-cell cytometry data using Spectre. Cytometry A. 2022;101(3):237–53.
pubmed: 33840138 doi: 10.1002/cyto.a.24350
Schagger H. Tricine-SDS-PAGE. Nat Protoc. 2006;1(1):16–22.
pubmed: 17406207 doi: 10.1038/nprot.2006.4
Maueroder C, Mahajan A, Paulus S, Gosswein S, Hahn J, Kienhofer D, et al. Menage-a-Trois: The Ratio of Bicarbonate to CO2 and the pH Regulate the Capacity of Neutrophils to Form NETs. Front Immunol. 2016;7:583.
pubmed: 28018350 pmcid: 5145884 doi: 10.3389/fimmu.2016.00583
Dedkova EN, Sigova AA, Zinchenko VP. Mechanism of action of calcium ionophores on intact cells: ionophore-resistant cells. Membr Cell Biol. 2000;13(3):357–68.
pubmed: 10768486
Douda DN, Khan MA, Grasemann H, Palaniyar N. SK3 channel and mitochondrial ROS mediate NADPH oxidase-independent NETosis induced by calcium influx. Proc Natl Acad Sci U S A. 2015;112(9):2817–22.
pubmed: 25730848 pmcid: 4352781 doi: 10.1073/pnas.1414055112
Parker H, Dragunow M, Hampton MB, Kettle AJ, Winterbourn CC. Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus. J Leukoc Biol. 2012;92(4):841–9.
pubmed: 22802447 doi: 10.1189/jlb.1211601
de Bont CM, Koopman WJH, Boelens WC, Pruijn GJM. Stimulus-dependent chromatin dynamics, citrullination, calcium signalling and ROS production during NET formation. Biochim Biophys Acta Mol Cell Res. 2018;1865(11 Pt A):1621–9.
pubmed: 30327203 doi: 10.1016/j.bbamcr.2018.08.014
Zhang J, Felder A, Liu Y, Guo LT, Lange S, Dalton ND, et al. Nesprin 1 is critical for nuclear positioning and anchorage. Hum Mol Genet. 2010;19(2):329–41.
pubmed: 19864491 doi: 10.1093/hmg/ddp499
Grady RM, Starr DA, Ackerman GL, Sanes JR, Han M. Syne proteins anchor muscle nuclei at the neuromuscular junction. Proc Natl Acad Sci U S A. 2005;102(12):4359–64.
pubmed: 15749817 pmcid: 555524 doi: 10.1073/pnas.0500711102
Banerjee I, Zhang J, Moore-Morris T, Pfeiffer E, Buchholz KS, Liu A, et al. Targeted ablation of nesprin 1 and nesprin 2 from murine myocardium results in cardiomyopathy, altered nuclear morphology and inhibition of the biomechanical gene response. PLoS Genet. 2014;10(2):e1004114.
pubmed: 24586179 pmcid: 3930490 doi: 10.1371/journal.pgen.1004114
Puckelwartz MJ, Kessler E, Zhang Y, Hodzic D, Randles KN, Morris G, et al. Disruption of nesprin-1 produces an Emery Dreifuss muscular dystrophy-like phenotype in mice. Hum Mol Genet. 2009;18(4):607–20.
pubmed: 19008300 doi: 10.1093/hmg/ddn386
Chancellor TJ, Lee J, Thodeti CK, Lele T. Actomyosin tension exerted on the nucleus through nesprin-1 connections influences endothelial cell adhesion, migration, and cyclic strain-induced reorientation. Biophys J. 2010;99(1):115–23.
pubmed: 20655839 pmcid: 2895377 doi: 10.1016/j.bpj.2010.04.011
Zhang Q, Bethmann C, Worth NF, Davies JD, Wasner C, Feuer A, et al. Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. Hum Mol Genet. 2007;16(23):2816–33.
pubmed: 17761684 doi: 10.1093/hmg/ddm238
Lu W, Schneider M, Neumann S, Jaeger VM, Taranum S, Munck M, et al. Nesprin interchain associations control nuclear size. Cell Mol Life Sci. 2012;69(20):3493–509.
pubmed: 22653047 pmcid: 11114684 doi: 10.1007/s00018-012-1034-1
Lindenboim L, Grozki D, Amsalem-Zafran AR, Pena-Blanco A, Gundersen GG, Borner C, et al. Apoptotic stress induces Bax-dependent, caspase-independent redistribution of LINC complex nesprins. Cell Death Discov. 2020;6(1):90.
pubmed: 33024575 pmcid: 7501853 doi: 10.1038/s41420-020-00327-6
Zhang Q, Skepper JN, Yang F, Davies JD, Hegyi L, Roberts RG, et al. Nesprins: a novel family of spectrin-repeat-containing proteins that localize to the nuclear membrane in multiple tissues. J Cell Sci. 2001;114(Pt 24):4485–98.
pubmed: 11792814 doi: 10.1242/jcs.114.24.4485
Croall DE, Ersfeld K. The calpains: modular designs and functional diversity. Genome Biol. 2007;8(6):218.
pubmed: 17608959 pmcid: 2394746 doi: 10.1186/gb-2007-8-6-218
Ayuso-Dolado S, Esteban-Ortega GM, Vidaurre OG, Diaz-Guerra M. A novel cell-penetrating peptide targeting calpain-cleavage of PSD-95 induced by excitotoxicity improves neurological outcome after stroke. Theranostics. 2021;11(14):6746–65.
pubmed: 34093851 pmcid: 8171078 doi: 10.7150/thno.60701
Stabach PR, Cianci CD, Glantz SB, Zhang Z, Morrow JS. Site-directed mutagenesis of alpha II spectrin at codon 1175 modulates its mu-calpain susceptibility. Biochemistry. 1997;36(1):57–65.
pubmed: 8993318 doi: 10.1021/bi962034i
Lofvenberg L, Backman L. Calpain-induced proteolysis of beta-spectrins. FEBS Lett. 1999;443(2):89–92.
pubmed: 9989581 doi: 10.1016/S0014-5793(98)01697-4
Dutta S, Chiu YC, Probert AW, Wang KK. Selective release of calpain produced alphalI-spectrin (alpha-fodrin) breakdown products by acute neuronal cell death. Biol Chem. 2002;383(5):785–91.
pubmed: 12108543 doi: 10.1515/BC.2002.082
Bano D, Dinsdale D, Cabrera-Socorro A, Maida S, Lambacher N, McColl B, et al. Alteration of the nuclear pore complex in Ca(2+)-mediated cell death. Cell Death Differ. 2010;17(1):119–33.
pubmed: 19713973 doi: 10.1038/cdd.2009.112
Liu ZX, Yu K, Dong J, Zhao L, Liu Z, Zhang Q, et al. Precise prediction of calpain cleavage sites and their aberrance caused by Mutations in Cancer. Front Genet. 2019;10:715.
pubmed: 31440276 pmcid: 6694742 doi: 10.3389/fgene.2019.00715
Saido TC, Nagao S, Shiramine M, Tsukaguchi M, Sorimachi H, Murofushi H, et al. Autolytic transition of mu-calpain upon activation as resolved by antibodies distinguishing between the pre- and post-autolysis forms. J Biochem. 1992;111(1):81–6.
pubmed: 1607367 doi: 10.1093/oxfordjournals.jbchem.a123723
Melloni E, Michetti M, Salamino F, Minafra R, Pontremoli S. Modulation of the calpain autoproteolysis by calpastatin and phospholipids. Biochem Biophys Res Commun. 1996;229(1):193–7.
pubmed: 8954105 doi: 10.1006/bbrc.1996.1779
Kobayashi S, Yamashita K, Takeoka T, Ohtsuki T, Suzuki Y, Takahashi R, et al. Calpain-mediated X-linked inhibitor of apoptosis degradation in neutrophil apoptosis and its impairment in chronic neutrophilic leukemia. J Biol Chem. 2002;277(37):33968–77.
pubmed: 12121983 doi: 10.1074/jbc.M203350200
Hoffmann K, Dreger CK, Olins AL, Olins DE, Shultz LD, Lucke B, et al. Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger-Huet anomaly). Nat Genet. 2002;31(4):410–4.
pubmed: 12118250 doi: 10.1038/ng925
Worman HJ. Components of the nuclear envelope and their role in human disease. Novartis Found Symp. 2005;264:35–42 discussion -50, 227–30.
pubmed: 15773746 doi: 10.1002/0470093765.ch4
Singh N, Johnstone DB, Martin KA, Tempera I, Kaplan MJ, Denny MF. Alterations in nuclear structure promote lupus autoimmunity in a mouse model. Dis Model Mech. 2016;9(8):885–97.
pubmed: 27483354 pmcid: 5007980
Singh J, Boettcher M, Dolling M, Heuer A, Hohberger B, Leppkes M, et al. Moonlighting chromatin: when DNA escapes nuclear control. Cell Death Differ. 2023;30(4):861–75.
pubmed: 36755071 pmcid: 9907214 doi: 10.1038/s41418-023-01124-1
Metzler KD, Goosmann C, Lubojemska A, Zychlinsky A, Papayannopoulos V. A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis. Cell Rep. 2014;8(3):883–96.
pubmed: 25066128 pmcid: 4471680 doi: 10.1016/j.celrep.2014.06.044
Liu ML. Functional actin cytoskeleton is required in early stage of NETosis induction. Proc Natl Acad Sci U S A. 2020;117(37):22653–4.
pubmed: 32943582 pmcid: 7502762 doi: 10.1073/pnas.2013790117
Yipp BG, Kubes P. NETosis: how vital is it? Blood. 2013;122(16):2784–94.
pubmed: 24009232 doi: 10.1182/blood-2013-04-457671
Neeli I, Dwivedi N, Khan S, Radic M. Regulation of extracellular chromatin release from neutrophils. J Innate Immun. 2009;1(3):194–201.
pubmed: 20375577 pmcid: 6951038 doi: 10.1159/000206974

Auteurs

Jeeshan Singh (J)

Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.

Leticija Zlatar (L)

Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.

Marco Muñoz-Becerra (M)

Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.

Günter Lochnit (G)

Protein Analytics, Institute of Biochemistry, Faculty of Medicine, Justus-Liebig-University Giessen, Giessen, Germany.

Irmgard Herrmann (I)

Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.

Felix Pfister (F)

Department of Otorhinolaryngology, Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Uniklinikum Erlangen, Erlangen, Germany.

Christina Janko (C)

Department of Otorhinolaryngology, Head and Neck Surgery, Section of Experimental Oncology and Nanomedicine (SEON), Uniklinikum Erlangen, Erlangen, Germany.

Jasmin Knopf (J)

Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
Department of Pediatric Surgery, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.

Moritz Leppkes (M)

Deutsches Zentrum Für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
Department of Medicine 1 - Gastroenterology, Pneumology and Endocrinology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.

Janina Schoen (J)

Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.

Luis E Muñoz (LE)

Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.

Georg Schett (G)

Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.

Martin Herrmann (M)

Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.

Christine Schauer (C)

Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.
Deutsches Zentrum Für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany.

Aparna Mahajan (A)

Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany. aparna.mahajan@fau.de.
Deutsches Zentrum Für Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany. aparna.mahajan@fau.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH